[1] Phetfong J, Sanvoranart T, Nartprayut K, et al. Osteoporosis: the current status of mesenchymal stem cell-based therapy[J]. Cell Mol Biol Lett, 2016, 12; 21:12.
[2] 邵雄杰, 罗春晓, 陈郁鲜. 脉冲电磁场对绝经后骨质疏松症的疗效分析[J]. 南方医科大学学报, 2008, 28(9): 1577-1578.
[3] McMillan LB, Zengin A, Ebeling PR, et al. Prescribing physical activity for the prevention and treatment of osteoporosis in older adults[J]. Healthcare (Basel), 2017 , 5(4). pii: E85.
[4] Zha DS, Zhu QA, Pei WW, et al. Does whole-body vibration with alternative tilting increase bone mineral density and change bone metabolism in senior people? [J]. Aging Clin Exp Res, 2012, 24(1):28-36.
[5] 郑锦畅,陈建庭,裴卫卫,等.复合振动仪治疗骨质疏松对骨代谢影响6 个月临床观察[J]. 中国骨质疏松杂志, 2010, 16(3):197-202,180.
[6] 邓轩赓, 陈建庭, 查丁胜. 低强度复合振动治疗去卵巢老龄大鼠骨质疏松实验研究[J]. 中国运动医学杂志, 2011, 30(3):265-269, 274.
[7] 裴卫卫,陈建庭,郑锦畅,等.复合振动仪治疗原发骨质疏松症的短期临床疗效观察[J]. 中国骨质疏松杂志, 2009, 15(9):657-660.
[8] Wu SH, Zhong ZM, Chen JT.Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells[J]. Int J Med Sci, 2012, 9(9):801-7.
[9] Cerciello S, Rossi S, Visonà E, et al.Clinical applications of vibration therapy in orthopaedic practice[J]. Muscles Ligaments Tendons J, 2016 , 6(1):147-156.
[10]Papachroni KK, Karatzas DN, Papavassiliou KA, et al. Mechanotransduction in osteoblast regulation and bone disease[J]. Trends Mol Med, 2009, 15(5): 208-216.
[11]Prisby RD, Lafage-Proust MH, Malaval L, et al. Effects of whole body vibration on the skeleton and other organ systems in man and animal models: what we know and what we need to know[J]. Ageing Res Rev, 2008, 7(4): 319-329.
[12]查丁胜, 陈建庭, 邓轩庚, 等. 不同频率振动应变对成骨细胞增殖及分化能力的影响[J]. 中国骨质疏松杂志, 2008, 14(5): 303-307,312.
[13]Prè D, Ceccarelli G, Benedetti L, et al. Effects of low-amplitude, high-frequency vibrations on proliferation and differentiation of SAOS-2 human osteogenic cell line[J]. Tissue Eng Part C Methods, 2009, 15(4): 669-679.
[14]Patel MJ, Chang KH, Sykes MC, et al. Low magnitude and high frequency mechanical loading prevents decreased bone formation responses of 2T3 preosteoblasts[J]. J Cell Biochem, 2009, 106(2): 306-316.
[15]Grimaud E, Soubigou L, Couillaud S, et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis[J]. Am J Pathol, 2003, 163(5): 2021-2031.
[16]Saunders MM, Taylor AF, Du C, et al. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells[J]. J Biomech, 2006, 39(8): 1419-1427.
[17]Tang L, Lin Z, Li YM. Effects of different magnitudes of mechanical strain on Osteoblasts in vitro[J]. Biochem Biophys Res Commun, 2006, 344(1): 122-128.
[18]Lau E, Al-Dujaili S, Guenther A, et al. Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts[J]. Bone, 2010, 46(6): 1508-1515.
[19]Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives[J]. J Endocrinol Invest, 2005, 28(10 Suppl): 8-13.
[20]钟招明. 生长分化因子-5诱导人黄韧带细胞成骨分化的作用及机制[D]. 广州: 南方医科大学博士学位论文, 2009.
[21]Jadlowiec J, Koch H, Zhang X, et al. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway[J]. J Biol Chem, 2004, 279(51): 53323-53330.
[22]Xiao Y, Haase H, Young WG, et al. Development and transplantation of a mineralized matrix formed by osteoblasts in vitro for bone regeneration[J]. Cell Transplant, 2004, 13(1): 15-25.
[23]李志香, 张春林, 谈诚. 30Hz全身振动对骨质疏松的影响[J]. 航天医学与医学工程, 2007, 20(2):116-119.
[24]金凤羽, 阮祥燕. 机械振动治疗绝经后女性膝骨性关节炎[J]. 中国组织工程研究与临床康复, 2007, 11(40): 8099-8102.
[25]李玮, 钟菁, 徐惠敏, 等. 全身振动对绝经后肥胖妇女肌力及抗骨折能力的影响[J]. 重庆医科大学学报, 2008, 33(3): 367-369, 375.
[26]Dharmapatni AASSK, Algate K, Coleman R, et al.Osteoclast-associated receptor (OSCAR) distribution in the synovial tissues of patients with active ra and TNF-α and RANKL regulation of expression by osteoclasts in vitro[J]. Inflammation, 2017, 40(5):1566-1575.
[27]Kunnen SJ, Leonhard WN, Semeins C, et al. Fluid shear stress-induced TGF-β/ALK5 signaling in renal epithelial cells is modulated by MEK1/2[J]. Cell Mol Life Sci, 2017, 74(12): 2283-2298.
[28]Zhai Y, Li Y, Wang Y, et al. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts[J]. Eur J Pharmacol, 2017, 801:62-71.
[29]Scheiner S, Pivonka P, Hellmich C. Poromicromechanics reveals that physiological bone strains induce osteocyte-stimulating lacunar pressure[J]. Biomech Model Mechanobiol, 2016, 15(1): 9-28. |